Crossmark

Daratumumab-based regimens for patients with multiple myeloma plus extramedullary plasmacytomas or paraskeletal plasmacytomas: initial follow-up of an Italian multicenter observational clinical experience

Crossref DOI link: https://doi.org/10.1007/s00277-024-05811-y

Published Online: 2024-05-28

Published Print: 2024-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mele, Giuseppe https://orcid.org/0000-0003-4813-8618
Derudas, Daniele

Conticello, Concetta

Barilà, Gregorio

Gentile, Massimo

Rocco, Stefano

Palmieri, Salvatore

Palazzo, Giulia

Germano, Candida

Reddiconto, Giovanni

Sgherza, Nicola

De Novellis, Danilo

Galeone, Carlotta

Castiglioni, Sara Agavni’

Deiana, Luca

Pascarella, Anna

Martino, Enrica Antonia

Foggetti, Ilaria

Blasi, Ilenia

Spina, Alessandro

Di Renzo, Nicola

Maggi, Alessandro

Tarantini, Giuseppe

Di Raimondo, Francesco

Specchia, Giorgina

Musto, Pellegrino

Pastore, Domenico
License Information

Text and Data Mining valid from 2024-05-28

Version of Record valid from 2024-05-28
More Information

Article History

Received: 26 December 2023

Accepted: 20 May 2024

First Online: 28 May 2024

Declarations

:

: The authors declare no competing interests.

: No potential conflict of interest was reported by the author(s).

Document is current

Any future updates will be listed below